- Research works
- 20 ▲ 6% vs 2013–17
- Citations
- 369 18.4 per fractional work
- Top-10% rate
- 19.7% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: PanGen Biotech (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.3×. Every wedge is a field page.
Which keywords describe research at PanGen Biotech (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, AAV, Viral Vectors, Gene Expression, Cell Culture, Glycosylation, Mammalian Cells and Recombinant Protein.
- Oxidative Stress
- Mammalian Cells
- Cell Culture
- Gene Expression
- AAV
- Gene Therapy
- Epidemiology
- Viral Vectors
- Glycosylation
- Recombinant Protein
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 10 words, with their numbers
- Gene Therapy2▲ 35×3 topics
- AAV2▲ 119×1 topic
- Epidemiology2▲ 1.93×6 topics
- Gene Expression2▲ 13×4 topics
- Viral Vectors2▲ 119×1 topic
- Cell Culture1▲ 63×2 topics
- Glycosylation1▲ 31×2 topics
- Mammalian Cells1▲ 169×1 topic
- Recombinant Protein1▲ 169×1 topic
- Oxidative Stress1▲ 2.9×5 topics
Which research topics does PanGen Biotech (South Korea) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects, Herpesvirus Infections and Treatments and Viral Infections and Immunology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 1 works
- 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 3 Herpesvirus Infections and Treatments Epidemiology 0 works
- 4 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
- 5 Pluripotent Stem Cells Research Molecular Biology 0 works
- 6 Molecular Biology Techniques and Applications Molecular Biology 0 works
- 7 Thermal Radiation and Cooling Technologies Civil and Structural Engineering 0 works
- 8 TGF-β signaling in diseases Molecular Biology 0 works
- 9 CRISPR and Genetic Engineering Molecular Biology 0 works
- 10 Muscle Physiology and Disorders Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PanGen Biotech (South Korea)'s research output changed?
Output in 2018–2022 was 6% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Suwon
- Ajou University
- Kyonggi University
- The Catholic University of Korea St. Vincent's Hospital
- National Institute of Agricultural Science and Technology
- Advanced Institute of Convergence Technology
- National Institute of Ecology
- Suwon Research Institute
- Ajou University Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.